Treatment options for small cell lung cancer – do we have more choice?
Published 2010 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment options for small cell lung cancer – do we have more choice?
Authors
Keywords
-
Journal
BRITISH JOURNAL OF CANCER
Volume 102, Issue 4, Pages 629-638
Publisher
Springer Nature
Online
2010-01-27
DOI
10.1038/sj.bjc.6605527
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Pemetrexed in Relapsed Small-Cell Lung Cancer and the Impact of Shortened Vitamin Supplementation Lead-In Time: Results of a Phase II Trial
- (2010) Mark A. Socinski et al. Journal of Thoracic Oncology
- The New Lung Cancer Staging System
- (2009) Frank C. Detterbeck et al. CHEST
- Japanese-US Common-Arm Analysis of Paclitaxel Plus Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Model for Assessing Population-Related Pharmacogenomics
- (2009) David R. Gandara et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase II Study of Picoplatin As Second-Line Therapy for Patients With Small-Cell Lung Cancer
- (2009) John R. Eckardt et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Trial of Irinotecan/Cisplatin Compared With Etoposide/Cisplatin in Extensive-Stage Small-Cell Lung Cancer: Clinical and Pharmacogenomic Results From SWOG S0124
- (2009) Primo N. Lara et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer
- (2009) Mark A. Socinski et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-angiogenic Therapy Using Thalidomide Combined With Chemotherapy in Small Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Trial
- (2009) Siow Ming Lee et al. JNCI-Journal of the National Cancer Institute
- CONVERT: Concurrent once-daily versus twice-daily radiotherapy – a new phase III randomised controlled trial for patients with limited-stage small cell lung cancer and good performance status
- (2009) C. Faivre-Finn et al. LUNG CANCER
- Lung cancer screening: the way forward
- (2008) J K Field et al. BRITISH JOURNAL OF CANCER
- Performance status and sensitivity to first-line chemotherapy are significant prognostic factors in patients with recurrent small cell lung cancer receiving second-line chemotherapy
- (2008) Young Hak Kim et al. CANCER
- Radiotherapy in Extensive-disease Small Cell Lung Cancer. A Survey of Current UK Practice
- (2008) N. Bayman et al. CLINICAL ONCOLOGY
- Irinotecan Plus Carboplatin Versus Oral Etoposide Plus Carboplatin in Extensive Small-Cell Lung Cancer: A Randomized Phase III Trial
- (2008) Andreas Hermes et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Study of Carboplatin and Etoposide With or Without thebcl-2Antisense Oligonucleotide Oblimersen for Extensive-Stage Small-Cell Lung Cancer: CALGB 30103
- (2008) Charles M. Rudin et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized Phase II Trial Comparing Amrubicin With Topotecan in Patients With Previously Treated Small-Cell Lung Cancer: North Japan Lung Cancer Study Group Trial 0402
- (2008) Akira Inoue et al. JOURNAL OF CLINICAL ONCOLOGY
- A prospective phase II study: High-dose pemetrexed as second-line chemotherapy in small-cell lung cancer
- (2008) Bjørn H. Grønberg et al. LUNG CANCER
- Comparison of gemcitabine and carboplatin versus cisplatin and etoposide for patients with poor-prognosis small cell lung cancer
- (2008) S M Lee et al. THORAX
- Phase II trial of thalidomide with chemotherapy and as maintenance therapy for patients with poor prognosis small-cell lung cancer
- (2007) Siow Ming Lee et al. LUNG CANCER
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started